Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis
Conclusions:
The AQuIA provided a consistent platform for analysis across multiple AF populations with varying baseline characteristics. Analyzer results show that many high-risk AF patients in selected commercial, Medicare-eligible, and Medicaid populations do not receive appropriate thromboprophylaxis, as recommended by treatment guidelines.
Source: BMC Health Services Research - Category: Journals (General) Authors: Kathleen LangDuygu BozkayaAarti PatelBrian MacomsonWinnie NelsonGary OwensSamir ModyJeff ScheinJoseph Menzin Source Type: research
More News: Atrial Fibrillation | Databases & Libraries | General Medicine | Medicaid | Medicare | Men | Stroke | Study